A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

Bacterial Vaginosis ◽

Controlled Trial ◽

Phase 3 ◽

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results

10.26226/morressier.5aeaf2d35800a00019097f88 ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Protease Inhibitor ◽

Controlled Trial ◽

Fixed Dose ◽

Phase 3 ◽

Randomized Controlled ◽

Tenofovir Alafenamide

A Single-Center, Phase 3, Randomized Controlled Trial of Pancreaticojejunostomy vs Pancreaticogastrostomy with Externalized Stent in High-Risk Pancreatic Anastomosis

SSRN Electronic Journal ◽

10.2139/ssrn.3476797 ◽

2019 ◽

Cited By ~ 1

Author(s):

Stefano Andrianello ◽

Giovanni Marchegiani ◽

Giuseppe Malleo ◽

Gaia Masini ◽

Alberto Balduzzi ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Single Center ◽

Phase 3 ◽

Pancreatic Anastomosis ◽

Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients with Dementia with Lewy Bodies: An Open-label Extension of a Phase 3 Randomized Controlled Trial

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2021.07.002 ◽

2021 ◽

Author(s):

Toshinari Odawara ◽

Kazuko Hasegawa ◽

Ritsuko Kajiwara ◽

Hisao Takeuchi ◽

Masaaki Tagawa ◽

...

Keyword(s):

Dementia With Lewy Bodies ◽

Controlled Trial ◽

Lewy Bodies ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Randomized Controlled ◽

Open Label Extension

SAT0392 Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of A Phase 3, Randomized, Controlled Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.4419 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 736.1-736 ◽

Cited By ~ 1

Author(s):

F. Zhang ◽

T. Tencer ◽

S. Li

Keyword(s):

Psoriatic Arthritis ◽

Controlled Trial ◽

Work Productivity ◽

Phase 3 ◽

Productivity Improvement ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Phosphodiesterase 4 Inhibitor

Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)

European Urology Oncology ◽

10.1016/j.euo.2021.04.008 ◽

2021 ◽

Author(s):

Michael J. Morris ◽

Jose Mauricio Mota ◽

Kristine Lacuna ◽

Patrick Hilden ◽

Martin Gleave ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Androgen Deprivation Therapy ◽

Controlled Trial ◽

Androgen Deprivation ◽

Recurrent Prostate Cancer ◽

Phase 3 ◽

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

PLoS Medicine ◽

10.1371/journal.pmed.1001685 ◽

2014 ◽

Vol 11 (7) ◽

pp. e1001685 ◽

Cited By ~ 221

Author(s):

Keyword(s):

Malaria Vaccine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Randomized Controlled ◽

Young Infants

Nutritional Results After Target Volume Reduction Of Intensity-Modulated Radiotherapy Following Induction Chemotherapy In Locoregionally Advanced Nasopharyngeal Cancer: A Phase 3, Multicenter, Randomized Controlled Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.290 ◽

2020 ◽

Vol 108 (3) ◽

pp. e803

Author(s):

L. Xiang ◽

J. Wu

Keyword(s):

Multicenter Randomized Controlled Trial

Induction Chemotherapy ◽

Controlled Trial ◽

Nasopharyngeal Cancer ◽

Intensity Modulated Radiotherapy ◽

Target Volume ◽

Phase 3 ◽

Intensity Modulated ◽

Randomized Controlled ◽

Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children

PLoS Neglected Tropical Diseases ◽

10.1371/journal.pntd.0006968 ◽

2018 ◽

Vol 12 (12) ◽

pp. e0006968 ◽

Cited By ~ 15

Author(s):

Gilles Riveau ◽

Anne-Marie Schacht ◽

Jean-Pierre Dompnier ◽

Dominique Deplanque ◽

Modou Seck ◽

...

Keyword(s):

Controlled Trial ◽

Phase 3 ◽

Urinary Schistosomiasis ◽

Safety And Efficacy ◽

LB0001 Long-Term (52-Week) Results of a Phase 3, Randomized, Controlled Trial of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.526 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A163-A163 ◽

Cited By ~ 5

Author(s):

A. Kavanaugh ◽

P. J. Mease ◽

A. O. Adebajo ◽

J. Wollenhaupt ◽

C. Hu ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Controlled Trial ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Phosphodiesterase 4 Inhibitor

SAT0402 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pharmacodynamic Results of A Phase 3, Randomized, Controlled Trial (PALACE 1)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.3878 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 739.4-740 ◽

Cited By ~ 1

Author(s):

P. Schafer ◽

P. Chen ◽

L. Fang ◽

A. Wang ◽

R. Chopra

Keyword(s):

Psoriatic Arthritis ◽

Controlled Trial ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Randomized Controlled ◽

Phosphodiesterase 4 Inhibitor